Torus Biosystems, Inc. — Form D/A
Torus Biosystems, Inc. of Cambridge, MA, a company, filed a Form D amendment with the SEC on 2021-03-18. The offering totals $3.0M, of which $2.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-03-18
- Form: D/A
- Accession: 0001802637-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.2M
- Remaining: $825K
- Investors: 4
- Date of first sale: 2020-12-17
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-384573
Issuer
- Name: Torus Biosystems, Inc.
- CIK: 0001802637
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 125 CambridgePark Drive, Cambridge, MA, 02140
- Phone: 617-921-4494
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Peng Yu Yin | Director | Cambridge, MA |
| Peng Yin | Director | Woburn, MA |
| Peng Yin | Executive Officer | Woburn, MA |
| Philip Gardella | Executive Officer | Cambridge, MA |
| Shawn Marcell | Director | Santa Clara, CA |
| Shawn Marcell | Executive Officer | Santa Clara, CA |
| David Yu Zhang | Director | Houston, TX |
| Ben Linden | Executive Officer | Cambridge, MA |
| Adam Yu Wiechhaus | Director | Cambridge, MA |
| Chenyang Victor Shi | Director | Brookline, MA |
| David Yu Zhang | Director | Brookline, MA |
Other filings by this issuer (3)
More